daprodustat
Ligand Summary
Daprodustat is a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase (PHD) developed for the treatment of anaemia in patients with chronic kidney disease (CKD). Inhibition of PHD prevents degradation of hypoxia-inducible factor (HIF), leading to the production of erythropoietin and subsequent induction of erythropoiesis.
UNII: JVR38ZM64B
PubChem: 91617630
ChEMBL: CHEMBL3544988
DrugCentral: 5421
LyCHI: CZATVQLWJ8Y1
Target Activities
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | INHIBITOR | |||||
IC50 | INHIBITOR | |||||
IC50 | INHIBITOR | |||||